| A comparison of the effectiveness of silibinin and resveratrol in preventing alpha‐amanitin‐induced hepatotoxicity A Sahin, MA Arici, Y Yilmaz, S Kalkan, N Durmus, BU Ergur, I Yakut Aksu, ... Basic & Clinical Pharmacology & Toxicology 122 (6), 633-642, 2018 | 16 | 2018 |
| The regulatory role of heparin on c-Met signaling in hepatocellular carcinoma cells E İşcan, A Güneş, P Korhan, Y Yılmaz, E Erdal, N Atabey Journal of Cell Communication and Signaling 11, 155-166, 2017 | 16 | 2017 |
| Platelets, microenvironment and hepatocellular carcinoma Y Yilmaz, E Erdal, N Atabey, IC Brian Biochem Anal Biochem 5 (2), 1-8, 2016 | 14 | 2016 |
| High glucose induced c-Met activation promotes aggressive phenotype and regulates expression of glucose metabolism genes in HCC cells H Topel, E Bağırsakçı, Y Yılmaz, A Güneş, G Bağcı, D Çömez, ... Scientific Reports 11 (1), 11376, 2021 | 7 | 2021 |
| Pleiotropic effects of heparins: from clinical applications to molecular mechanisms in hepatocellular carcinoma P Korhan, Y Yılmaz, E Bağırsakçı, A Güneş, H Topel, BI Carr, N Atabey Canadian Journal of Gastroenterology and Hepatology 2018, 2018 | 6 | 2018 |
| Role of biobanks for cancer research and precision medicine in hepatocellular carcinoma P Korhan, S Tercan Avcı, Y Yılmaz, Y Öztemur Islakoğlu, N Atabey Journal of Gastrointestinal Cancer, 1-16, 2021 | 3 | 2021 |
| Signaling pathways as potential therapeutic targets in hepatocarcinogenesis Y Yılmaz, A Güneş, H Topel, N Atabey Journal of Gastrointestinal Cancer 48, 225-237, 2017 | 2 | 2017 |
| Targeting c-Met and AXL Crosstalk for the Treatment of Hepatocellular Carcinoma Y Yılmaz, T Batur, P Korhan, M Öztürk, N Atabey Liver Cancer in the Middle East, 333-364, 2021 | 1 | 2021 |
| c-Met activation promotes extravasation of hepatocellular carcinoma cells into 3D-cultured hepatocyte cells in lab-on-a-chip device G Bagci, D Comez, H Topel, Y Yilmaz, E Bagirsakci, A Gunes, GB Ayaz, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1870 (8), 119557, 2023 | | 2023 |
| PO-179 Identification of C-Met and insulin receptor heterodimer as a mediator for hepatocellular carcinoma Y Yilmaz, H Topel, N Atabey ESMO Open 3, A297, 2018 | | 2018 |
| PO-181 Predicting homing ability of hepatocellular carcinoma cells by using a lab-on-a-chip system H Topel, Y Yilmaz, A Gunes, E Bagirsakci, BA Gizem, D Comez, G Bagci, ... ESMO Open 3, A91-A92, 2018 | | 2018 |
| Reciprocal interaction of c-Met receptor tyrosine kinase and lncRNA HOTAIR in hepatocellular carcinoma H Topel, D Comez, Y Yilmaz, SN Atabey FEBS JOURNAL 284, 350-350, 2017 | | 2017 |
